Koyfin Home > Directory > Health Care > Amicus Therapeutics > Price / Book

Amicus Therapeutics Price / Book Chart (FOLD)

Amicus Therapeutics annual/quarterly Price / Book from 2007 to 2018. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Amicus Therapeutics Price / Book for the quarter ending March 03, 2018 was 7.12 a 34.98% increase of 2.49 year over year
  • Amicus Therapeutics Annual Price / Book for 2017 was 5.81 a 63.86% increase of 3.71 from 2016
  • Amicus Therapeutics Annual Price / Book for 2016 was 2.10 a -51.90% decrease of -1.09 from 2015
  • Amicus Therapeutics Annual Price / Book for 2015 was 3.19 a -377.44% decrease of -12.05 from 2014
Other Valuation Metrics:
  • Amicus Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,811m a 48.80% increase of 1,372m year over year
  • Amicus Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $2,617m a 49.70% increase of 1,301m year over year
View Chart On Koyfin

Quarterly FOLD Price / Book Data

03/20187.12
12/20175.81
09/20178.10
06/20174.63
03/20172.82
12/20162.10
09/20162.98
06/20162.19
03/20163.04
12/20153.19

Annual FOLD Price / Book Data

20175.81
20162.10
20153.19
201415.24
20134.40
20121.72
20113.24
20102.57
20092.42
20082.17